rs782129661
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_001110556.2(FLNA):c.6937G>A(p.Glu2313Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00000415 in 1,206,054 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 25)
Exomes 𝑓: 0.0000037 ( 0 hom. 2 hem. )
Consequence
FLNA
NM_001110556.2 missense
NM_001110556.2 missense
Scores
1
13
3
Clinical Significance
Conservation
PhyloP100: 6.00
Publications
0 publications found
Genes affected
FLNA (HGNC:3754): (filamin A) The protein encoded by this gene is an actin-binding protein that crosslinks actin filaments and links actin filaments to membrane glycoproteins. The encoded protein is involved in remodeling the cytoskeleton to effect changes in cell shape and migration. This protein interacts with integrins, transmembrane receptor complexes, and second messengers. Defects in this gene are a cause of several syndromes, including periventricular nodular heterotopias (PVNH1, PVNH4), otopalatodigital syndromes (OPD1, OPD2), frontometaphyseal dysplasia (FMD), Melnick-Needles syndrome (MNS), and X-linked congenital idiopathic intestinal pseudoobstruction (CIIPX). Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2009]
FLNA Gene-Disease associations (from GenCC):
- periventricular nodular heterotopiaInheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- frontometaphyseal dysplasia 1Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
- genetic developmental and epileptic encephalopathyInheritance: XL Classification: DEFINITIVE Submitted by: G2P
- heterotopia, periventricular, X-linked dominantInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Illumina
- intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linkedInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Melnick-Needles syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- otopalatodigital syndrome type 2Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- terminal osseous dysplasia-pigmentary defects syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- cardiac valvular dysplasia, X-linkedInheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- frontometaphyseal dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital short bowel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- otopalatodigital syndrome type 1Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Ehlers-Danlos syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- familial thoracic aortic aneurysm and aortic dissectionInheritance: XL Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP6
Variant X-154351667-C-T is Benign according to our data. Variant chrX-154351667-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 585873.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL,AD,AR gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FLNA | ENST00000369850.10 | c.6937G>A | p.Glu2313Lys | missense_variant | Exon 43 of 48 | 1 | NM_001110556.2 | ENSP00000358866.3 |
Frequencies
GnomAD3 genomes AF: 0.00000887 AC: 1AN: 112802Hom.: 0 Cov.: 25 show subpopulations
GnomAD3 genomes
AF:
AC:
1
AN:
112802
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000110 AC: 2AN: 181069 AF XY: 0.00 show subpopulations
GnomAD2 exomes
AF:
AC:
2
AN:
181069
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000366 AC: 4AN: 1093252Hom.: 0 Cov.: 30 AF XY: 0.00000557 AC XY: 2AN XY: 358918 show subpopulations
GnomAD4 exome
AF:
AC:
4
AN:
1093252
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
358918
show subpopulations
African (AFR)
AF:
AC:
0
AN:
26305
American (AMR)
AF:
AC:
0
AN:
35200
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19354
East Asian (EAS)
AF:
AC:
0
AN:
30189
South Asian (SAS)
AF:
AC:
0
AN:
54041
European-Finnish (FIN)
AF:
AC:
2
AN:
40184
Middle Eastern (MID)
AF:
AC:
0
AN:
4119
European-Non Finnish (NFE)
AF:
AC:
2
AN:
837919
Other (OTH)
AF:
AC:
0
AN:
45941
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00000887 AC: 1AN: 112802Hom.: 0 Cov.: 25 AF XY: 0.00 AC XY: 0AN XY: 34950 show subpopulations
GnomAD4 genome
AF:
AC:
1
AN:
112802
Hom.:
Cov.:
25
AF XY:
AC XY:
0
AN XY:
34950
show subpopulations
African (AFR)
AF:
AC:
0
AN:
31026
American (AMR)
AF:
AC:
0
AN:
10790
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2661
East Asian (EAS)
AF:
AC:
0
AN:
3607
South Asian (SAS)
AF:
AC:
0
AN:
2743
European-Finnish (FIN)
AF:
AC:
0
AN:
6308
Middle Eastern (MID)
AF:
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
AC:
1
AN:
53225
Other (OTH)
AF:
AC:
0
AN:
1516
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Mar 12, 2018
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Melnick-Needles syndrome;C0265293:Frontometaphyseal dysplasia;C1844696:Oto-palato-digital syndrome, type II;C1848213:Heterotopia, periventricular, X-linked dominant Benign:1
Mar 07, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D;.;.;.;.;.
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;.;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;.;.;.;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;.;D;D;.;D
REVEL
Uncertain
Sift
Uncertain
D;.;D;D;.;D
Sift4G
Uncertain
D;D;D;D;D;D
Polyphen
B;.;B;B;.;.
Vest4
MutPred
Gain of methylation at E2313 (P = 0.0104);.;.;.;.;.;
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.